Recap: Zepp Health Q4 Earnings
Portfolio Pulse from Benzinga Insights
Zepp Health (NYSE:ZEPP) reported Q4 earnings with a significant miss on estimated earnings by -75.0%, posting an EPS of $0.01 against an estimate of $0.04. Revenue also saw a decrease, down $70.92 million from the same period last year. This follows a pattern of missed EPS estimates in previous quarters, with the company's share price experiencing a 0.0% change the day after last quarter's earnings were announced.
March 18, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zepp Health reported a significant miss in Q4 earnings with a -75.0% deviation from estimated EPS and a notable year-over-year revenue decrease.
The substantial miss in both EPS and revenue for Zepp Health is likely to negatively impact investor sentiment and stock price in the short term. Historical data shows that past earnings misses have not significantly affected the stock price the next day, but the magnitude of this miss, especially in consecutive quarters, could lead to a different outcome.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100